Cite
HARVARD Citation
Vergote, I. et al. (n.d.). TP004/#1457 Trial in progress of engot-CX8/GOG-3024/innovaTV 205: addition of a new cohort using first-line tisotumab vedotin + pembrolizumab + carboplatin ± bevacizumab in recurrent/metastatic cervical cancer. International journal of gynecological cancer. p. A225. [Online].